Patents by Inventor Evan GOMES

Evan GOMES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EXTERNAL WORKING CHANNELS
    Publication number: 20240081619
    Abstract: Apparatuses (e.g., devices, systems, etc.) and methods that may provide access to one or more tools to a remote site in the body including expandable and external working channels that may be part of a tube that is coupled to an outer surface of an elongate medical device, such as an endoscope.
    Type: Application
    Filed: August 18, 2023
    Publication date: March 14, 2024
    Inventors: Alexander Q. TILSON, Mark C. SCHEEFF, Garrett J. GOMES, Francisco G. LOPEZ, Justin KIRSCHBROWN, Wei Li FAN, William EVANS, Viet Anh NGUYEN, Stephan T. HOFFMANN, Kassidy MACPHAIL, Thomas HSIU
  • In vitro neonatal biomimetic (nMIMIC) model and methods of using same
    Patent number: 11156601
    Abstract: In vitro biomimetic models of the neonatal immune system are provided along with methods of using the models in pre-clinical assessment of infant immune cell-mediated and humoral responses to immunogenic stimulation, such as vaccination. The models include one comprising cord blood-derived T follicular helper cells and B cells, and one comprising cord blood-derived dendritic cells and CD4+ T cells. The models can be used, for example, to assess candidate vaccines via analysis of cellular responses to antigen and vaccine exposure.
    Type: Grant
    Filed: September 7, 2017
    Date of Patent: October 26, 2021
    Assignee: SANOFI PASTEUR VAXDESIGN CORPORATION
    Inventors: Evan Gomes, Tirumalai Kamala, Luis Mosquera, Vaughan Wittman, William Warren, Janice Moser, Donald Drake
  • IN VITRO NEONATAL BIOMIMETIC (NMIMIC) MODEL AND METHODS OF USING SAME
    Publication number: 20190187127
    Abstract: In vitro biomimetic models of the neonatal immune system are provided along with methods of using the models in pre-clinical assessment of infant immune cell-mediated and humoral responses to immunogenic stimulation, such as vaccination. The models include one comprising cord blood-derived T follicular helper cells and B cells, and one comprising cord blood-derived dendritic cells and CD4+ T cells. The models can be used, for example, to assess candidate vaccines via analysis of cellular responses to antigen and vaccine exposure.
    Type: Application
    Filed: September 7, 2017
    Publication date: June 20, 2019
    Applicant: Sanofi Pasteur VaxDesign Corporation
    Inventors: Evan GOMES, Tirumalai KAMALA, Luis MOSQUERA, Vaughan WITTMAN, William WARREN, Janice MOSER, Donald DRAKE